Dyspepsia natural history, complications and prognosis

Dyspepsia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dyspepsia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dyspepsia natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dyspepsia natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dyspepsia natural history, complications and prognosis
CDC on Dyspepsia natural history, complications and prognosis
Dyspepsia natural history, complications and prognosis in the news
Blogs on Dyspepsia natural history, complications and prognosis
Directions to Hospitals Treating Dyspepsia
Risk calculators and risk factors for Dyspepsia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahad Hasan, M.D.[2] Ajay Gade MD[3]]

Overview

Dyspepsia is a symptom complex referable to the gastroduodenal region that includes epigastric pain or burning, postprandial fullness, and early satiety. Approximately 80% of individuals with dyspepsia have no structural or biochemical explanation for their symptoms after investigation and are labeled as having functional dyspepsia (FD), which affects up to 16% of otherwise healthy individuals in the general population. Dyspepsia usually persists throughout life as a chronic, relapsing-remitting condition, and spontaneous, permanent resolution is rare. Dyspepsia, particularly its organic subtype, is most commonly associated with Helicobacter pylori infection, while functional dyspepsia frequently overlaps with gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS), an overlap associated with a more severe and persistent symptom course. The increasing prevalence of dyspepsia with age, together with an increased risk of peptic ulcers in individuals with persistent symptoms, underlies the rationale for age- and alarm feature-based investigation strategies recommended by current guidelines. Complications of dyspepsia when an underlying organic cause is present include peptic ulcers, anemia due to gastritis or ulcer-related blood loss, stomach cancer or esophageal cancer, vitamin B12 deficiency, and pernicious anemia. Fewer than 1–3% of patients presenting with dyspepsia harbor an underlying upper gastrointestinal malignancy, but alarm features have limited sensitivity (11.6–29.3%), and approximately one in four patients with upper gastrointestinal cancer lack alarm features at diagnosis. Functional dyspepsia carries an excellent prognosis with normal life expectancy regardless of H. pylori status, but it is associated with substantial impairment in quality of life and a high burden of psychological comorbidity, and outcomes are worse when FD overlaps with GERD or IBS.

Natural History

• Dyspepsia usually persists throughout life as a chronic, relapsing-remitting condition, and complete spontaneous resolution is uncommon.
• In more than 50% of patients presenting with uninvestigated dyspepsia, and up to 80% in population-based cohorts, no obvious organic cause is identified on investigation, a condition termed functional dyspepsia. Functional dyspepsia affects up to 16% of otherwise healthy individuals in the general population and is subdivided into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS), which frequently overlap and can transition from one to the other over time.
• Organic dyspepsia is most commonly associated with Helicobacter pylori infection; increasing age, and an increased risk of peptic ulcers have been observed in individuals with persistent dyspepsia and chronic gastritis.
• Increase in the prevalence of dyspepsia is attributed to increasing age, and the age of onset and clinical pattern vary among different ethnicities.
• Functional dyspepsia frequently overlaps with other disorders of gut-brain interaction. In a longitudinal cohort of 807 individuals meeting Rome IV criteria for IBS, 446 (55.3%) also met criteria for FD; those with IBS-FD overlap had significantly more severe and continuous abdominal pain, greater limitation of daily activities, higher rates of physician consultation and new treatment initiation, and higher rates of abnormal anxiety, depression, and somatization scores at follow-up compared with IBS alone.
• Overlap between FD and GERD is also common and alters the natural history and diagnostic yield of endoscopy. Among patients clinically fulfilling Rome IV criteria for FD, gastroduodenal ulcer was found in 0.6% of those without reflux symptoms compared with 4.7% of those with overlapping reflux symptoms, and 20.7% of this cohort had clinically significant endoscopic findings, including reflux esophagitis in 16.6%.
• Risk factors associated with the development and persistence of functional dyspepsia include psychological comorbidity, prior acute gastroenteritis (post-infectious FD), female sex, cigarette smoking, use of non-steroidal anti-inflammatory drugs, and Helicobacter pylori infection.

Complications

• Peptic ulcers
• Anemia due to gastritis or ulcer-related blood loss
• Stomach cancer and esophageal cancer
• Vitamin B12 deficiency
• Pernicious anemia
• Increased risk of developing benign or malignant growths in the lining of the stomach
• Chronic impairment of quality of life and elevated psychological comorbidity, including anxiety and depression
• Upper gastrointestinal malignancy accounts for approximately 1–3% of patients presenting with dyspepsia; the risk rises substantially in patients ≥60 years of age or those with alarm features, although alarm features alone have limited diagnostic accuracy.

The table below summarizes the diagnostic performance of alarm features for upper gastrointestinal malignancy in patients with dyspepsia, based on systematic review and meta-analysis data:

Alarm Feature Test Characteristic	Range Reported
Specificity for malignancy	93.8%–99.8%
Negative predictive value	93.8%–99.8%
Sensitivity for malignancy	11.6%–29.3%
Positive predictive value	11.6%–29.3%
Proportion of upper GI cancers presenting without alarm features	~25% (1 in 4 patients)

Differentiating organic from functional causes of persistent or complicated dyspepsia is essential, as management and prognosis differ substantially:

Category	Examples	Distinguishing Features
Functional (no structural cause)	Functional dyspepsia (postprandial distress syndrome, epigastric pain syndrome)	Normal endoscopy; chronic, relapsing course; excellent long-term prognosis
Peptic/acid-related	Peptic ulcer disease, H. pylori gastritis, gastroesophageal reflux disease	Epigastric pain relieved/worsened by food, heartburn, regurgitation; responds to acid suppression
Neoplastic	Gastric cancer, esophageal cancer, pancreatic cancer	Alarm features (weight loss, dysphagia, GI bleeding, iron-deficiency anemia, palpable mass, age ≥60 with new-onset symptoms)
Biliary/pancreatic	Cholelithiasis, chronic pancreatitis	Right upper quadrant or epigastric pain radiating to back, association with fatty food, abnormal liver function tests or lipase
Drug-induced	NSAIDs, bisphosphonates, iron supplementation, antibiotics	Temporal relationship to medication use; resolves with discontinuation
Systemic/metabolic	Diabetic gastroparesis, thyroid disease, chronic kidney disease	Associated systemic symptoms and abnormal metabolic panel
Other structural	Gastric outlet obstruction, malrotation, celiac disease	Vomiting, early satiety, weight loss, or malabsorptive symptoms

Prognosis

Functional dyspepsia is a long-lasting disorder with an excellent prognosis and normal life expectancy regardless of H. pylori infection status, but it is associated with a considerable reduction in health-related quality of life and substantial healthcare utilization and cost.

• Anxiety and depression are markedly more prevalent in patients with functional dyspepsia than in healthy controls (anxiety 50.4% vs 13.3%; depression 42.4% vs 6.66%), with higher mean anxiety scores (7.93 vs 4.17) and depression scores (6.94 vs 3.40); symptom severity correlates positively with anxiety/depression scores and negatively with quality of life.
• Overlap with IBS or GERD worsens prognosis: patients with IBS-FD overlap report more severe, continuous abdominal pain, greater activity limitation, higher rates of new treatment initiation, and higher anxiety, depression, and somatization scores than those with IBS alone.
• Although the overall risk of upper gastrointestinal malignancy in dyspepsia is low, prognosis is guideline-dependent on appropriate risk stratification; the ACG/CAG and BSG guidelines recommend prompt endoscopy in patients ≥60 years of age (or a locally-defined threshold) or those with alarm features, given that approximately one in four upper GI cancers present without alarm features.
• Organic dyspepsia due to Helicobacter pylori-associated peptic ulcer disease has a favorable prognosis with eradication therapy, which heals ulcers and reduces the long-term risk of recurrent peptic ulcers, gastritis-related anemia, and progression to gastric cancer.
• An increased risk of developing peptic ulcers has been observed in individuals with persistent dyspepsia and chronic gastritis.